S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:PETQ

PetIQ (PETQ) Stock Forecast, Price & News

$19.56
-0.36 (-1.81%)
(As of 09/25/2023 ET)
Compare
Today's Range
$19.35
$20.17
50-Day Range
$15.98
$20.71
52-Week Range
$6.66
$20.86
Volume
288,828 shs
Average Volume
266,287 shs
Market Capitalization
$575.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.75

PetIQ MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
26.5% Upside
$24.75 Price Target
Short Interest
Bearish
5.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.03mentions of PetIQ in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
54.00%
From $0.50 to $0.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

650th out of 962 stocks

Drugs, Proprietaries, & Sundries Industry

7th out of 7 stocks


PETQ stock logo

About PetIQ (NASDAQ:PETQ) Stock

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

PETQ Price History

PETQ Stock News Headlines

PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last?
PetIQ (NASDAQ:PETQ) Trading 4.9% Higher
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
PetIQ: Q2 Earnings Snapshot
PetIQ Inc - Ordinary Shares - Class A
Positive Signs As Multiple Insiders Buy PetIQ Stock
PetIQ: Steady Growth Play
PetIQ: Looking Smarter, If Margins Return
Earnings Outlook For PetIQ
PetIQ: Q1 Earnings Snapshot
See More Headlines
Receive PETQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.

PETQ Company Calendar

Last Earnings
8/08/2023
Today
9/25/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
1,888
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.75
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+26.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-48,210,000.00
Pretax Margin
-3.60%

Debt

Sales & Book Value

Annual Sales
$921.51 million
Cash Flow
$3.00 per share
Book Value
$7.25 per share

Miscellaneous

Free Float
26,686,000
Market Cap
$575.46 million
Optionable
Optionable
Beta
1.93
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. McCord ChristensenMr. McCord Christensen (Age 51)
    Chairman & CEO
  • Mr. Michael A. SmithMr. Michael A. Smith (Age 45)
    Pres & COO
    Comp: $1.34M
  • Mr. Zvi Glasman (Age 59)
    Chief Financial Officer
    Comp: $1.06M
  • William J. Carter
    Exec. VP & Gen. Counsel
  • Mr. John Pearson
    Exec. VP of Services & Manufactured Products













PETQ Stock - Frequently Asked Questions

Should I buy or sell PetIQ stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PETQ shares.
View PETQ analyst ratings
or view top-rated stocks.

What is PetIQ's stock price forecast for 2023?

3 Wall Street analysts have issued 1 year price objectives for PetIQ's shares. Their PETQ share price forecasts range from $16.00 to $30.00. On average, they expect the company's stock price to reach $24.75 in the next year. This suggests a possible upside of 26.5% from the stock's current price.
View analysts price targets for PETQ
or view top-rated stocks among Wall Street analysts.

How have PETQ shares performed in 2023?

PetIQ's stock was trading at $9.22 on January 1st, 2023. Since then, PETQ stock has increased by 112.1% and is now trading at $19.56.
View the best growth stocks for 2023 here
.

When is PetIQ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our PETQ earnings forecast
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) posted its earnings results on Tuesday, August, 8th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.18 by $0.19. The company had revenue of $314.55 million for the quarter, compared to analyst estimates of $274.19 million. PetIQ had a negative net margin of 3.68% and a positive trailing twelve-month return on equity of 8.53%.

What ETFs hold PetIQ's stock?

ETFs with the largest weight of PetIQ (NASDAQ:PETQ) stock in their portfolio include ProShares Pet Care ETF (PAWZ).Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).

What guidance has PetIQ issued on next quarter's earnings?

PetIQ issued an update on its third quarter 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $220.00 million-$240.00 million, compared to the consensus revenue estimate of $226.90 million.

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ Chief Executive Officer Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among the company's employees.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Who are PetIQ's major shareholders?

PetIQ's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.11%), Aristotle Capital Boston LLC (4.37%), Boston Partners (3.73%), Nepsis Inc. (3.26%), Goldman Sachs Group Inc. (2.73%) and Brandywine Global Investment Management LLC (2.58%). Insiders that own company stock include Allan Hall, John Newland, Mark L First, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Zvi Glasman.
View institutional ownership trends
.

How do I buy shares of PetIQ?

Shares of PETQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $19.56.

How much money does PetIQ make?

PetIQ (NASDAQ:PETQ) has a market capitalization of $575.46 million and generates $921.51 million in revenue each year. The company earns $-48,210,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis.

How many employees does PetIQ have?

The company employs 1,888 workers across the globe.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The official website for the company is www.petiq.com. The company can be reached via phone at (208) 939-8900 or via email at jeff.sonnek@icrinc.com.

This page (NASDAQ:PETQ) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -